New
HealthMore in Health→
AI liver cancer tool shows strong real-world results
Key Takeaways
- LiON was trained on 6,443 patients and retrospectively validated across 22,251 patients.
- In a 10,333-patient routine-practice trial, the system achieved an AUC of 0.952 and met its primary endpoint.
- AI-human collaboration identified 51 previously overlooked lesions, including 15 malignancies.
DE
DT Editorial Team··via nature.com